|
Sign In to gain access to subscriptions and/or personal tools.
|
Invited Review: Selection of Optimal Lipid Sources in Enteral and Parenteral Nutrition
Michele M. Gottschlich, PHD, RD, CNSD
Nutrition Services, Shriners Burns Institute, Cincinnati
The manipulation of dietary fat intake can affect the response to disease, injury, and infection. These effects include enhancement or inhibition of immune function, altered susceptibility to cardiovascular disease, promotion or maintenance of gut integrity, and prevention of total parenteral nutrition-induced hepatic dysfunction. These effects may occur as a result of changes in the fatty acid composition of biomembranes or changes in concentrations of lipid moieties such as prostaglandins or leukotrienes. Those fats that have been shown to affect physiologic function include long-chain, medium-chain, and short-chain fatty acids and -3 and -6 fatty acids. Currently available enteral and parenteral products used for nutrition support contain widely varied amounts of these different fatty acids. Therefore, the selection of the most appropriate product or nutrition support regimen for an individual patient requires an understanding of the metabolism of these different fat substrates, their therapeutic indications, and the contraindications and controversies that surround their use. This article reviews these issues and also focuses on several alternate lipid sources such as short-chain fatty acids, medium-chain fatty acids, -3 fatty acids, and blended and structured lipids.
Nutrition in Clinical Practice, Vol. 7, No. 4,
152-165 (1992)
DOI: 10.1177/0115426592007004152

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Terada, M. Takizawa, S. Yamamoto, O. Ezaki, H. Itakura, and K. S. Akagawa
Eicosapentaenoic acid inhibits CSF-induced human monocyte survival and maturation into macrophage through the stimulation of H2O2 production
J. Leukoc. Biol.,
June 1, 2002;
71(6):
981 - 986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gross, R. Babst, A. Juretic, B. Herzog, P. Stehle, L. Filgueira, M. Oberholzer, F. Gudat, and M. Heberer
Intralipid-Based Short-Term Total Parenteral Nutrition Does Not Impair Small Intestinal Mucosa-Related Cellular Immune Reactivity in the Healthy Rat
JPEN J Parenter Enteral Nutr,
November 1, 2000;
24(6):
337 - 344.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-J. Lo, K. C. Chiu, M. Fu, A. Chu, and S. Helton
Fish Oil Modulates Macrophage P44/P42 Mitogen-Activated Protein Kinase Activity Induced By Lipopolysaccharide
JPEN J Parenter Enteral Nutr,
May 1, 2000;
24(3):
159 - 163.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Mattox
Specialized Nutrition Management of Patients Receiving Hematopoietic Stem Cell Transplantation
Nutr Clin Pract,
February 1, 1999;
14(1):
5 - 15.
[Abstract]
[PDF]
|
 |
|
|
|